BTW
CME icon

Boston Trust Walden’s CME Group CME Stock Holding History

Boston Trust Walden’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.83M Buy
17,351
+2,200
+15% +$609K 0.03% 238
2026
Q1 		$4.47M Buy
15,151
+702
+5% +$209K 0.04% 238
2025
Q4 		$3.95M Sell
14,449
-665
-4% -$181K 0.03% 232
2025
Q3 		$4.08M Sell
15,114
-1,045
-6% -$284K 0.03% 232
2025
Q2 		$4.45M Sell
16,159
-560
-3% -$152K 0.03% 226
2025
Q1 		$4.44M Buy
16,719
+150
+0.9% +$37K 0.03% 226
2024
Q4 		$3.85M Buy
16,569
+935
+6% +$215K 0.03% 232
2024
Q3 		$3.45M Buy
15,634
+14,604
+1,418% +$3.02M 0.02% 236
2024
Q2 		$202K Buy
1,030
+100
+11% +$20.7K ﹤0.01% 375
2024
Q1 		$200K Buy
+930
New +$195K ﹤0.01% 370
2023
Q4 		– Sell
-1,148
Closed -$230K – 376
2023
Q3 		$230K Sell
1,148
-2,602
-69% -$517K ﹤0.01% 351
2023
Q2 		$695K Buy
3,750
+50
+1% +$9.24K 0.01% 295
2023
Q1 		$709K Buy
+3,700
New +$669K 0.01% 293

Other funds holding CME

PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
GAM
Guinness Asset Management London, United Kingdom $5.91B AUM 21.44% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Boston Trust Walden's CME Position: Q2 2026 in Review

Boston Trust Walden increased its CME Group (CME) stake by 15% in Q2 2026, buying an estimated $609K and bringing the position to 17,351 shares worth $3.83M. The position accounts for 0.03% of the portfolio, ranked #238.

Boston Trust Walden first reported a position in CME in Q1 2023 and has held it in 13 quarters since. The position peaked at $4.47M in Q1 2026. 629 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Boston Trust Walden held 17,351 shares of CME Group worth $3.83M as of Q2 2026.
  • Boston Trust Walden bought 2,200 CME Group shares in Q2 2026, an estimated $609K.
  • CME Group made up 0.03% of Boston Trust Walden's portfolio in Q2 2026, its #238 holding.
  • Boston Trust Walden first reported a position in CME Group in Q1 2023 and has held it in 13 quarters since.
  • Boston Trust Walden's CME Group position peaked at $4.47M in Q1 2026.
  • 629 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.